Boyle Scott N
SEC insider (Form 3/4/5 filer). CIK 0001913897. Chief Business Officer at C4 Therapeutics, Inc. (CCCC). 14 reported Form 4/5 transactions since Sep 2024; latest on Feb 14, 2026. Located in WATERTOWN, MA.
Companies Boyle Scott N has filed insider reports for
- C4 Therapeutics, Inc. (CCCC): Officer, Chief Business Officer
Boyle Scott N
CIK: 0001913897
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
C4 Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Feb 14, 2026CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect7.3K shares at avg. $1.89$14K - Feb 14, 2026CCCC
C4 Therapeutics, Inc.
ExerciseDirect21K shares- - Feb 13, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect200K shares- - Feb 13, 2026CCCC
C4 Therapeutics, Inc.
ExerciseDirect5K shares- - Feb 13, 2026CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect1.7K shares at avg. $1.89$3K - Feb 18, 2025CCCC
C4 Therapeutics, Inc.
SaleDirect669 shares at avg. $3.15$2K - Feb 14, 2025CCCC
C4 Therapeutics, Inc.
SaleDirect490 shares at avg. $3.15$2K - Feb 14, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect56.5K shares- - Feb 14, 2025CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect2.4K shares at avg. $3.18$8K - Feb 13, 2025CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect1.7K shares at avg. $3.20$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc. | Tax Payment | 7,269 | $1.89 | $13,738 | Direct |
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc. | Exercise | 20,950 | - | $0 | Direct |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc. | Award | 200,000 | - | $0 | Direct |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc. | Exercise | 5,000 | - | $0 | Direct |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc. | Tax Payment | 1,735 | $1.89 | $3,279 | Direct |
| Feb 18, 2025 | CCCC C4 Therapeutics, Inc. | Sale | 669 | $3.15 | $2,107 | Direct |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | Sale | 490 | $3.15 | $1,544 | Direct |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | Award | 56,500 | - | - | Direct |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | Tax Payment | 2,368 | $3.18 | $7,530 | Direct |
| Feb 13, 2025 | CCCC C4 Therapeutics, Inc. | Tax Payment | 1,735 | $3.20 | $5,552 | Direct |
1-10 of 14 transactions